Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence

Daniel A Salmon^{1

2

3}, Matthew Z Dudley^{1

3}, Bruce C Carleton^{4

5

6}

Affiliations

¹ Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
² Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
³ Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada.
⁵ British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
⁶ Pharmaceutical Outcomes Program, British Columbia Children's Hospital, Vancouver, Canada.

Daniel A Salmon et al. J Infect Dis. 2021.

. 2021 Feb 13;223(3):355-358.

doi: 10.1093/infdis/jiaa544.

Daniel A Salmon^{1

2

3}, Matthew Z Dudley^{1

3}, Bruce C Carleton^{4

5

6}

¹ Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
² Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
³ Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada.
⁵ British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
⁶ Pharmaceutical Outcomes Program, British Columbia Children's Hospital, Vancouver, Canada.

No abstract available

Keywords: Guillain-Barré syndrome; adversomics; influenza vaccine; vaccine confidence; vaccine hesitancy; vaccine safety; vaccinomics.

Comment in

1. Grohskopf LA , Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR Morb Mortal Wkly Rep 2019; 68:1–21. - PMC - PubMed
1. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza—United States, 1976–2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057–62. - PubMed
1. Thompson WW , Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333–40. - PubMed
1. Kostova D , Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005–2011. PLoS One 2013; 8:e66312. - PMC - PubMed
1. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2018–19 influenza season. https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Accessed 19 August 2020.